PROLX PHARMACEUTICALS CORP.
6Patents
2Active
6Granted
31Portfolio score
Filing activity: Jul 31, 1998 → Apr 17, 2006 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7399785B2 | N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor | Chemistry; Metallurgy | 11 | Expired |
| US6372772B1 | Inhibitors of redox signaling and methods of using same | Human Necessities | 11 | Expired |
| US6552060B1 | Asymmetric disulfides and methods of using same | Chemistry; Metallurgy | 8 | Expired |
| US7081475B2 | Wortmannin analogs and methods of using same | Chemistry; Metallurgy | 6 | Expired |
| US7446124B2 | Wortmannin analogs and methods of using same in combination with chemotherapeutic agents | Chemistry; Metallurgy | 3 | Active |
| US7629128B2 | Methods of identifying respondents to hypoxia inducible factor 1-α inhibitors | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.